Good morning :)
$
₹
Stevanato Group SpA

Stevanato Group SpA

STVN

NYSE
Asset Logo

Stevanato Group SpA

STVN

NYSE
$21.471.01% (-0.22)
$
₹
$21.471.01% (-0.22)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Medical Instruments & Supplies

Mid Cap

With a market cap of $5.9B the stock is ranked 1330

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

38.75
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.33
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$0.56
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.55
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

10.99%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

0%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 11 analysts' reports

Buy
8 analysts
Hold
3 analysts
Sell
0 analyst

Analysts expect a +14.71% price upside over the next year

Current Price$21.47
Target Price$24.67

Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass converting machines; and after-sales services, such as line optimization and line conversions, training, logistics, spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug products, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Peers

Peers

Abbott Laboratories
ABT
Abbott Laboratories
P/E Ratio
33.20
33.20
1Y Return
24.55%
24.55%
Buy Reco %
74.07
74.07
Danaher Corporation
DHR
Danaher Corporation
P/E Ratio
37.75
37.75
1Y Return
13.52%
13.52%
Buy Reco %
88.00
88.00
Intuitive Surgical Inc
ISRG
Intuitive Surgical Inc
P/E Ratio
45.05
45.05
1Y Return
9.65%
9.65%
Buy Reco %
66.66
66.66
Medtronic PLC
MDT
Medtronic PLC
P/E Ratio
22.69
22.69
1Y Return
2.29%
2.29%
Buy Reco %
53.12
53.12
Stryker Corporation
SYK
Stryker Corporation
P/E Ratio
28.48
28.48
1Y Return
27.34%
27.34%
Buy Reco %
68.75
68.75

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareMedical Instruments & Supplies

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Stevanato Group SpA 38.753.331.55
Abbott Laboratories33.203.471.88
Danaher Corporation37.752.831.26

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

303.1
36
343.2
47.1
273.5
28
302
23
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue235.99259.57277.86330.59256.59280.03303.16343.25273.57302
Net Income18.8120.6230.0248.3126.5129.7036.0647.1528.0223
Net Profit Margin7.97%7.94%10.80%14.61%10.33%10.60%11.89%13.73%10.24%7.61%
See CostsAll values in $ Million

Frequently asked questions

  1. Stevanato Group SpA (STVN) share price today is $21.47 as of September 22, 2026 at 1:30 AM IST. The stock touched a day high of $22.13 and a day low of $21.19.

  2. Stevanato Group SpA stock trades on NYSE under the ticker symbol STVN.

  3. Stevanato Group SpA's market capitalization is $5.92B as of September 22, 2026 at 1:30 AM IST.

  4. Stevanato Group SpA's price-to-earnings (P/E) ratio is 38.75 as of September 21, 2026.

  5. Stevanato Group SpA's price-to-book (P/B) ratio is 3.33 as of September 21, 2026.

  6. No, Stevanato Group SpA does not currently pay a dividend.

  7. Yes, You can buy Stevanato Group SpA shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Stevanato Group SpA shares in three steps: 1. Search Stevanato Group SpA on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Stevanato Group SpA trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Stevanato Group SpA (STVN) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.4655 shares at the current price of $21.47.

Loading...